Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer
{{output}}
Background: Homologous recombination deficiency (HRD) originating from inactivation of genes like BRCA1/BRCA2 is a targetable abnormality common in triple-negative breast cancer (TNBC). In estrogen-receptor (ER)-positive HER2-neg... ...
